Clinical trials for Neuromyelitis Optica
28 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT05909761Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During PregnancyAmgen · PI: MD
- RECRUITINGPhase 3NCT05199688A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)Hoffmann-La Roche · PI: Clinical Trials
- RECRUITINGPhase 4NCT07420296Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum DisorderTianjin Medical University General Hospital
- RECRUITINGNCT06885957Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSDTongji Hospital
- RECRUITINGPhase 1NCT06620809The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum DisordersTongji Hospital · PI: Dai-shi Tian, MD
- RECRUITINGN/ANCT06865274Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGN/ANCT06780709Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSDIcahn School of Medicine at Mount Sinai · PI: Sammita Satyanarayan, MD
- ACTIVE NOT RECRUITINGPhase 3NCT06724809Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSDAlexion Pharmaceuticals, Inc. · PI: Xiangjun Chen, M.D
- ENROLLING BY INVITATIONN/ANCT06374264Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum DisorderMedRhythms, Inc. · PI: Eric Klawiter, MD
- RECRUITINGPHASE2, PHASE3NCT06413654A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)Shanghai Jiaolian Drug Research and Development Co., Ltd
- RECRUITINGNCT06398158Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum DisorderUniversity of Texas Southwestern Medical Center · PI: Darin T. Okuda, MD
- ACTIVE NOT RECRUITINGPhase 4NCT06180278Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)Amgen · PI: MD
- RECRUITINGNCT05966467Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor TherapiesAlexion Pharmaceuticals, Inc. · PI: Pablo Lopez
- ENROLLING BY INVITATIONNCT06643858Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)Beijing Tiantan Hospital · PI: Yaou Liu, Doctor
- ACTIVE NOT RECRUITINGNCT06767020Comparative Study on AQP4 Antibody Detection MethodsFirst Affiliated Hospital of Chongqing Medical University · PI: Jinzhou Feng, Ph.D
- RECRUITINGN/ANCT05566769Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSDAd scientiam
- ACTIVE NOT RECRUITINGPhase 2NCT06044350A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum DisordersBio-Thera Solutions · PI: Xiangjun Chen, Doctor
- RECRUITINGPhase 2NCT05549258Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum DisorderAmgen · PI: MD
- RECRUITINGPHASE1, PHASE2NCT05792462Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum DisordersTianjin Medical University General Hospital · PI: Qiang Liu, M.D.,PhD
- ACTIVE NOT RECRUITINGPhase 3NCT05730699Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)Biocad
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05403138Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum DisordersTianjin Medical University General Hospital
- ACTIVE NOT RECRUITINGPhase 3NCT05314010A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)Beijing Mabworks Biotech Co., Ltd.
- RECRUITINGPHASE1, PHASE2NCT05504694Ofatumumab in AQP4-IgG Seropositive NMOSDTang-Du Hospital · PI: Jun Guo, M.D.
- RECRUITINGPHASE2, PHASE3NCT05346354Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSDAlexion Pharmaceuticals, Inc.
- ENROLLING BY INVITATIONNCT05982925Longitudinal Cortical Demyelination in Multiple Sclerosis and Related DisordersIcahn School of Medicine at Mount Sinai · PI: Erin S Beck, MD, PhD
- RECRUITINGEarly Phase 1NCT05145361Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)Shanghai Pharmaceuticals Holding Co., Ltd · PI: Fu-Dong Shi, MD,PhD
- ENROLLING BY INVITATIONNCT04886492CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)CorEvitas
- RECRUITINGNCT03900221French Registry for Monitoring Pregnancies for Multiple SclerosisHospices Civils de Lyon · PI: Sandra VUKUSIC, Prof.